Ategenos Secures Foundational U.S. Patent for First SmartPatch Platform Targeting $1T+ Medication Non-Adherence Crisis
Only platform enabling real-time detection and intervention for medication non-adherence at community scale Ategenos, a pharmatech company tackling the $1T global cost of medication non-adherence, today announced it has been awarded a foundational U.S. patent protecting the core architecture of its wearable SmartPatch™platform. The patent positions Ategenos as a category-defining innovator at the convergence of […]